Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis
ABSTRACT Objective: To assess actual data on the safety, effectiveness, and hemodynamic performance of Bovine Pericardium Organic Valvular Bioprosthesis (BVP). Methods: The BIOPRO Trial is an observational, retrospective, non-comparative, non-randomized, and multicenter study. We collected data fr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Cirurgia Cardiovascular
2023-08-01
|
| Series: | Brazilian Journal of Cardiovascular Surgery |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382023000600203&lng=en&tlng=en |
| _version_ | 1797739569404182528 |
|---|---|
| author | Álvaro Machado Rösler Fernando Antonio Lucchese Pablo Maria Alberto Pomerantzeff Luiz Carlos Santana Passos |
| author_facet | Álvaro Machado Rösler Fernando Antonio Lucchese Pablo Maria Alberto Pomerantzeff Luiz Carlos Santana Passos |
| author_sort | Álvaro Machado Rösler |
| collection | DOAJ |
| description | ABSTRACT Objective: To assess actual data on the safety, effectiveness, and hemodynamic performance of Bovine Pericardium Organic Valvular Bioprosthesis (BVP). Methods: The BIOPRO Trial is an observational, retrospective, non-comparative, non-randomized, and multicenter study. We collected data from 903 patients with symptomatic, moderate, or severe valve disease who underwent BVP implants in the timeframe from 2013 to 2020 at three Brazilian institutions. Death, valve-related adverse events (AEs), functional recovery, and hemodynamic performance were evaluated at the hospital, at discharge, and six months and one year later. Primary analysis compared late (> 30 days after implant) linearized rates of valve-related AEs, such as thromboembolism, valve thrombosis, major hemorrhage, major paravalvular leak, and endocarditis, following objective performance criteria (OPC). Analysis was performed to include at least 400 valve-years for each valve position (aortic and mitral) for complete comparisons to OPC. Kaplan-Meier survival and major adverse cardiovascular and cerebrovascular event analyses were also performed. Results: This retrospective study analyzed follow-up data collected from 903 patients (834.2 late patient-years) who have undergone surgery for 455 isolated aortic valve replacement (50.4%), 382 isolated mitral valve replacement (42.3%), and 66 combined valve replacement or other intervention (7.3%). The linearized rates of valve-related AEs were < 2 × OPC. One-year survival rates were 95.1% and 92.7% for aortic and mitral valve replacement, respectively. This study demonstrated an improvement in the New York Heart Association classification from baseline and hemodynamic performance within an expected range. Conclusion: According to this analysis, BVP meets world standards for safety and clinical efficacy. |
| first_indexed | 2024-03-12T14:00:03Z |
| format | Article |
| id | doaj.art-b5be29e0a4b645e0a2ef43bc26e4c6f4 |
| institution | Directory Open Access Journal |
| issn | 1678-9741 |
| language | English |
| last_indexed | 2024-03-12T14:00:03Z |
| publishDate | 2023-08-01 |
| publisher | Sociedade Brasileira de Cirurgia Cardiovascular |
| record_format | Article |
| series | Brazilian Journal of Cardiovascular Surgery |
| spelling | doaj.art-b5be29e0a4b645e0a2ef43bc26e4c6f42023-08-22T07:43:54ZengSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery1678-97412023-08-0138610.21470/1678-9741-2023-0015Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular BioprosthesisÁlvaro Machado Röslerhttps://orcid.org/0000-0003-4727-3367Fernando Antonio LucchesePablo Maria Alberto PomerantzeffLuiz Carlos Santana PassosABSTRACT Objective: To assess actual data on the safety, effectiveness, and hemodynamic performance of Bovine Pericardium Organic Valvular Bioprosthesis (BVP). Methods: The BIOPRO Trial is an observational, retrospective, non-comparative, non-randomized, and multicenter study. We collected data from 903 patients with symptomatic, moderate, or severe valve disease who underwent BVP implants in the timeframe from 2013 to 2020 at three Brazilian institutions. Death, valve-related adverse events (AEs), functional recovery, and hemodynamic performance were evaluated at the hospital, at discharge, and six months and one year later. Primary analysis compared late (> 30 days after implant) linearized rates of valve-related AEs, such as thromboembolism, valve thrombosis, major hemorrhage, major paravalvular leak, and endocarditis, following objective performance criteria (OPC). Analysis was performed to include at least 400 valve-years for each valve position (aortic and mitral) for complete comparisons to OPC. Kaplan-Meier survival and major adverse cardiovascular and cerebrovascular event analyses were also performed. Results: This retrospective study analyzed follow-up data collected from 903 patients (834.2 late patient-years) who have undergone surgery for 455 isolated aortic valve replacement (50.4%), 382 isolated mitral valve replacement (42.3%), and 66 combined valve replacement or other intervention (7.3%). The linearized rates of valve-related AEs were < 2 × OPC. One-year survival rates were 95.1% and 92.7% for aortic and mitral valve replacement, respectively. This study demonstrated an improvement in the New York Heart Association classification from baseline and hemodynamic performance within an expected range. Conclusion: According to this analysis, BVP meets world standards for safety and clinical efficacy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382023000600203&lng=en&tlng=enAortic ValveBioprosthesisAnimalsHeart Valve ProsthesisHemodynamicsProsthesis DesignTreatment Outcomes |
| spellingShingle | Álvaro Machado Rösler Fernando Antonio Lucchese Pablo Maria Alberto Pomerantzeff Luiz Carlos Santana Passos Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis Brazilian Journal of Cardiovascular Surgery Aortic Valve Bioprosthesis Animals Heart Valve Prosthesis Hemodynamics Prosthesis Design Treatment Outcomes |
| title | Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis |
| title_full | Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis |
| title_fullStr | Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis |
| title_full_unstemmed | Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis |
| title_short | Safety, Effectiveness, and Hemodynamic Performance of the Bovine Pericardium Organic Valvular Bioprosthesis |
| title_sort | safety effectiveness and hemodynamic performance of the bovine pericardium organic valvular bioprosthesis |
| topic | Aortic Valve Bioprosthesis Animals Heart Valve Prosthesis Hemodynamics Prosthesis Design Treatment Outcomes |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382023000600203&lng=en&tlng=en |
| work_keys_str_mv | AT alvaromachadorosler safetyeffectivenessandhemodynamicperformanceofthebovinepericardiumorganicvalvularbioprosthesis AT fernandoantoniolucchese safetyeffectivenessandhemodynamicperformanceofthebovinepericardiumorganicvalvularbioprosthesis AT pablomariaalbertopomerantzeff safetyeffectivenessandhemodynamicperformanceofthebovinepericardiumorganicvalvularbioprosthesis AT luizcarlossantanapassos safetyeffectivenessandhemodynamicperformanceofthebovinepericardiumorganicvalvularbioprosthesis |